KATHRYN BOOR, PH.D.
Corporate Board Profile
Tech Score:
0
/100
← Back to All Directors
Sarepta Therapeutics, Inc.
Filing Date
Source Excerpt
2022-04-25
Kathryn Boor is a director nominee for Class I recommended by our nominating and corporate governance committee.
Data sourced from SEC filings. Last updated: 2025-12-06